Search research articles
Contact Us
Filters
Showing results (181-190 of 309) with videos related to
Page
of 31
Sort By:
Cancer Cytopathology
|
April 7, 2021
Clinical evaluation of p16<sup>INK4a</sup> immunocytology in cervical cancer screening: A population-based cross-sectional study from rural China
Remila Rezhake, Yan Wang, Feng Chen, et al.
Journal of Clinical Pathology
|
November 16, 2021
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
Ramya Bhatia, Elia Alcaniz Boada, Jesper Hansen Bonde, et al.
Annals of Internal Medicine
|
November 15, 2016
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis
Marc Arbyn, Lan Xu, Freija Verdoodt, et al.
BMC Cancer
|
November 18, 2023
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial
Patrycja Glinska, Katarzyna Komerska, Beata Janik, et al.
Journal of Medical Virology
|
June 7, 2024
Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay
Pui Yan Jenny Chung, Sharonjit K Dhillon, Alice Baraquin, et al.
Journal of Medical Virology
|
September 13, 2023
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay
Sharonjit K Dhillon, Pui Yan Jenny Chung, Elizaveta Padalko, et al.
Gynecologic Oncology
|
December 2, 2025
Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program
Monjura Nisha, Ya-Lun Liang, Deborah Bateson, et al.
Virology Journal
|
February 24, 2023
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol
Sharonjit K Dhillon, Cindy Simoens, Lize Cuypers, et al.
The Lancet. Global Health
|
December 17, 2022
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
Deependra Singh, Jerome Vignat, Valentina Lorenzoni, et al.
International Journal of Cancer
|
May 22, 2012
The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy
Marc Arbyn, Jolien Roelens, Kate Cuschieri, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 309) with videos related to
Sort By:
Page
of 31
Cancer Cytopathology
|
April 7, 2021
Clinical evaluation of p16<sup>INK4a</sup> immunocytology in cervical cancer screening: A population-based cross-sectional study from rural China
Remila Rezhake, Yan Wang, Feng Chen, et al.
Journal of Clinical Pathology
|
November 16, 2021
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
Ramya Bhatia, Elia Alcaniz Boada, Jesper Hansen Bonde, et al.
Annals of Internal Medicine
|
November 15, 2016
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis
Marc Arbyn, Lan Xu, Freija Verdoodt, et al.
BMC Cancer
|
November 18, 2023
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial
Patrycja Glinska, Katarzyna Komerska, Beata Janik, et al.
Journal of Medical Virology
|
June 7, 2024
Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay
Pui Yan Jenny Chung, Sharonjit K Dhillon, Alice Baraquin, et al.
Journal of Medical Virology
|
September 13, 2023
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay
Sharonjit K Dhillon, Pui Yan Jenny Chung, Elizaveta Padalko, et al.
Gynecologic Oncology
|
December 2, 2025
Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program
Monjura Nisha, Ya-Lun Liang, Deborah Bateson, et al.
Virology Journal
|
February 24, 2023
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol
Sharonjit K Dhillon, Cindy Simoens, Lize Cuypers, et al.
The Lancet. Global Health
|
December 17, 2022
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
Deependra Singh, Jerome Vignat, Valentina Lorenzoni, et al.
International Journal of Cancer
|
May 22, 2012
The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy
Marc Arbyn, Jolien Roelens, Kate Cuschieri, et al.
Page
of 31